Serum Phospholipases A2 in Patients Undergoing Panproctocolectomy Because of Severe Ulcerative Colitis1

Clinical Chemistry and Laboratory Medicine

Volumn 35, Issue 10, 1997, Pages 749-754

  Haapamäki, Markku M ^a   Grönroos, Juha M ^a   Pekkala, Erkki ^a   Jokilammi Siltanen, Anne ^a   Nevalainen, Timo J ^a   Irjala, Kerttu ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CITRATE BINDING TRANSPORT PROTEIN; CITRATE-BINDING TRANSPORT PROTEIN; PHOSPHOLIPASE A; ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CORTICOSTEROID; HYDROCORTISONE; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; PHOSPHOLIPASE A2; PREDNISONE;

ADULT; AGED; ARTICLE; BLOOD; COLON; COLON RESECTION; ENZYMOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; ULCERATIVE COLITIS; CLINICAL ARTICLE; ENZYME BLOOD LEVEL; PRIORITY JOURNAL; PROCTOCOLECTOMY;

ADULT; AGED; CARRIER PROTEINS; COLECTOMY; COLITIS, ULCERATIVE; COLON; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPASES A; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES;

EID: 0030609095     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1997.35.10.749     Document Type: Article

References (43)

1. van den Bosch H. Review: intracellular phospholipases A. Biochim Biophys Acta 1980; 604: 191-246.
2. Bereziat G, Etienne J, Kokkinidis M, Olivier JL, Pemas P. New trends in mammalian non-pancreatic phospholipase A2 research. J Lipid Mediat 1990; 2: 159-172.
3. Vadas P, Browning J, Edelson J, Pruzanski W. Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states. J Lipid Mediat 1993; 8: 1-30.
4. Heinrikson RL, Krueger ET, Keim PS. Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus ada-manteus. A new classification of phospholipases A2 based upon structural determinants. J Biol Chem 1977; 252: 4913-4921.
5. Dennis EA. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 1997; 22: 1-2.
6. Recklies AD, White C. Phospholipase A2 is a major component of the salt-extractable pool of matrix proteins in adult human articular cartilage. Arthritis Rheum 1991; 34: 1106-1115.
7. Nevalainen TJ, Marki F, Kortesuo PT, Griitter MG, Di Marco S, Schmitz A. Synovial type (group II) phospholipase A2 in cartilage. J Rheumatol 1993; 20: 325-330.
8. Kiyohara H, Egami H, Shibata Y, Murata K, Ohshima S, Ogawa M. Light microscopic immunohistochemical analysis of the distribution of group II phospholipase A2 in human digestive organs.J Histochem Cytochem 1992; 40: 1659-1664.
9. Haapamaki MM, Gronroos JM, Nurmi H, Alanen K, Kallajoki M, Nevalainen TJ. Gene expression of group II phospholipase A2 in intestine in ulcerative colitis. Gut 1997; 40: 95-101.
10. Nevalainen T, Haapanen T. Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues. Inflammation 1993; 17: 453-464.
11. Nevalainen TJ, Meri KM, Niemi M. Synovial-type (group II) phospholipase A2 human seminal plasma. Andrologia 1993; 25: 355-358.
12. Pruzanski W, Vadas P. Phospholipase A2-a mediator between proximal and distal effectors of inflammation. Immunol Today 1991; 12: 143-146.
13. Crowl RM, Stoller TJ, Conroy RR, Stoner CR. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991; 266: 2647-2651.
14. Nevalainen T. Review: serum phospholipases A2 in inflammatory diseases. Clin Chem 1993; 39: 2453-2459.
15. Minami T, Tojo H, Shinomura Y, Tarui S, Okamoto M. Raised serum activity of phospholipase A2 immunochemically related to group II Enzymein inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut 1992; 33: 914-921.
16. Minami T, Shinomura Y, Miyagawa J, Tojo H, Okamoto M, Matsuzawa Y. Immunohistochemical localization of group II phospholipase A2 in colonic mucosa of patients with inflammatory bowel disease. Am J Gastroenterol 1997; 92: 289-292.
17. Santavuori SA, Kortesuo PT, Eskola JU, Nevalainen TJ. Application of a new monoclonal antibody for time-resolved fluoro-immunoassay of human pancreatic phospholipase A2. Eur J Clin Chem Clin Biochem 1991; 29: 819-826.
18. Nevalainen T, Kortesuo P, Rintala E, Marki F. Immunochemical detection of group I and group II phospholipases A2 in human serum. Clin Chem 1992; 38: 1824-1829.
19. Schadlich HR, Biichler M, Beger HG. Improved method for the determination of phospholipase A2 catalytic activity concentration in human serum and ascites. J Clin Chem Clin Biochem 1987; 25: 505-509.
20. Vadas P, Hay JB. Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock. Can J Physiol Pharmacol 1983; 61: 561-566.
21. Stommer P, Steinmann U. Phospholipase A2 induced diffuse alveolar damage-effect of indomethacin and dexamethasone upon morphology and plasma-histamine level. Klin Wochenschr 1989; 67: 171-176.
22. Gronroos JM, Kuttila K, Nevalainen TJ. Group II phospholipase A2 in serum in critically ill surgical patients. Crit Care Med 1994; 22: 956-959.
23. Gronroos JM, Forsstrom JJ, Hjala K, Nevalainen TJ. Phospholipase A2, C-reactive protein, and white blood cell count in the diagnosis of acute appendicitis. Clin Chem 1994; 40: 1757-1760.
24. Laine VJO, Gronroos JM, Nevalainen TJ. Serum phospholipase A2 in patients after splenectomy. Eur J Clin Chem Clin Biochem 1996; 34: 419-422.
25. Nevalainen TJ, Gronroos JM, Kallajoki M. Expression of group II phospholipase A2 in the human gastrointestinal tract. Lab Invest 1995; 72: 201-208.
26. Ogawa M, Arakawa H, Yamashita S, Sakamoto K, Ikei S. Postoperative elevations of serum interleukin 6 and group II phospholipase A2: group II phospholipase A2 in serum is an acute phase reactant. Res Commun Chem Pathol Pharmacol 1992; 75: 109-115.
27. Gronroos JM, Kuttila K, Perttila J, Nevalainen TJ. Serum phospholipases A2 after aortobifemoral reconstruction. Eur J Clin Chem Clin Biochem 1995; 33: 271-274.
28. Gronroos JM, Kuttila K, Perttila J, Nevalainen TJ. Phospholipases A2 in the serum of patients after coronary artery bypass surgery. Crit Care Med 1996; 24: 259-262.
29. Hietaranta AJ, Aho HJ, Gronroos JM, Hua ZY, Nevalainen TJ. Pancreatic phospholipase A2 in proximal tubules of rat kidney in experimental acute pancreatitis and after intravenous injection of the enzyme. Pancreas 1992; 7: 326-333.
30. Murakami M, Kudo I, Inoue K. In vivo release and clearance of rat platelet phospholipase A2. Biochim Biophys Acta 1989; 1005: 270-276.
31. Vadas P, Pruzanski W, Farewell V. A predictive model for the clearance of soluble phospholipase A2 during septic shock. J Lab Clin Med 1991; 118: 471-475.
32. Nevalainen TJ, Kallajoki M, Pesonen E, Andersson S, Karkkainen P, Hockerstedt K. Origin of circulating group II phospholipase A2 in hepatocytes in a patient with epitheloid hemangioendothelioma of the liver. Lab Invest 1996; 74: 585-591.
33. Matsuda Y, Ogawa M, Sakamoto K, 'Yamashita S, Kanda A, Kohno M, et al. Development of a radioimmunoassay for human group-II phospholipase A2 and demonstration of postoperative elevation. Enzyme 1991; 45: 200-208.
34. Engstrom L, Tomgren S, Rohdin Aim C. Peroperative endotoxin concentrations in portal and peripheral venous blood in patients undergoing right hemicolectomy for carcinoma. Eur J Surg 1992; 158: 301-305.
35. van Goor H, Rosman C, Grand J, Kooi K, Wubbels GH, Bleichrodt RP. Translocation of bacteria and endotoxin in organ donors. Arch Surg 1994; 129: 1063-1066.
36. Lilja I, Dimberg J, Sjödahl R, Tagesson C, Gustafson-Svärd C. Effects of endotoxin and dexamethasone on group I and II phospholipase A2 in rat ileum and stomach. Gut 1994; 35: 40-45.
37. Santos AA, Browning JL, Scheltinga MR, Lynch EA, Brown EF, Lawton P, et al. Are events after endotoxemia related to circulating phospholipase A2? Ann Sing 1994; 219: 183-192.
38. Pruzanski W, Mackensen A, Engelhardt R, Stefanski E, Vadas P. Induction of circulating phospholipase A2 activity by intravenous infusion of endotoxin in patients with neoplasia. J Immunother 1992; 12: 242-246.
39. Palmer KR, Duerden BI, Holdsworth CD. Bacteriological and endotoxin studies in cases of ulcerative colitis. Gut 1980; 21: 851-854.
40. Gardiner KR, Anderson NH, Rowlands BJ, Barbul A. Colitis and colonic mucosal barrier dysfunction. Gut 1995; 37: 530-535.
41. Rosenthal MD, Gordon MN, Buescher ES, Slusser JH, Harris LK, Franson RC. Human neutrophils store type II 14-kDa phospholipase A2 in granules and secrete active Enzyme in response to soluble stimuli. Biochem Biophys Res Commun 1995; 208: 650-656.
42. Sorenson DK, Kelly TM, Murray DK, Nelson DH. Corticosteroids stimulate an increase in phospholipase A2 inhibitor in human serum. J Steroid Biochem 1988; 29: 271-273.
43. Vadas P, Pruzanski W, Stefanski E, Ruse J, Farewell V, McLaughlin J, et al. Concordance of endogenous cortisol and phospholipase A2 levels in gram-negative septic shock: a prospective study. J Lab Clin Med 1988; 111: 584-590.